SLC7A6OS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.148200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.498400E-01
Normal-vs-Stage2
5.397600E-01
Normal-vs-Stage3
1.758020E-01
Normal-vs-Stage4
9.871000E-01
Stage1-vs-Stage2
4.673000E-01
Stage1-vs-Stage3
2.309600E-01
Stage1-vs-Stage4
3.647900E-02
Stage2-vs-Stage3
7.430400E-02
Stage2-vs-Stage4
5.356100E-02
Stage3-vs-Stage4
1.359990E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.173200E-01
Normal-vs-AfricanAmerican
3.495600E-01
Normal-vs-Asian
1.733020E-01
Caucasian-vs-AfricanAmerican
9.924000E-01
Caucasian-vs-Asian
4.245800E-01
AfricanAmerican-vs-Asian
6.423600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.228200E-01
Normal-vs-Female
5.069200E-01
Male-vs-Female
7.635400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.673200E-01
Normal-vs-Age(41-60Yrs)
5.523400E-01
Normal-vs-Age(61-80Yrs)
4.846600E-01
Normal-vs-Age(81-100Yrs)
5.461600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.619200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.666000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.246800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.877950E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.282000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.059430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.221400E-01
Normal-vs-Daily Drinker
4.408200E-01
Normal-vs-Weekly Drinker
4.548800E-01
Normal-vs-Occasional Drinker
6.322400E-01
Normal-vs-Social Drinker
5.103000E-01
Non Drinker-vs-Daily Drinker
3.957000E-01
Non Drinker-vs-Weekly Drinker
5.185400E-01
Non Drinker-vs-Occasional Drinker
3.447800E-01
Non Drinker-vs-Social Drinker
9.100400E-01
Daily Drinker-vs-Weekly Drinker
9.000200E-01
Daily Drinker-vs-Occasional Drinker
1.018830E-01
Daily Drinker-vs-Social Drinker
4.996600E-01
Weekly Drinker-vs-Occasional Drinker
1.389640E-01
Weekly Drinker-vs-Social Drinker
5.753600E-01
Occasional Drinker-vs-Social Drinker
2.904800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.200800E-01
Normal-vs-Grade 2
5.773800E-01
Normal-vs-Grade 3
5.821800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.230300E-04
Grade 1-vs-Grade 3
1.016130E-04
Grade 1-vs-Grade 4
5.200800E-01
Grade 2-vs-Grade 3
1.211210E-01
Grade 2-vs-Grade 4
5.773800E-01
Grade 3-vs-Grade 4
5.821800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.303400E-01
Normal-vs-NonDiabetic
4.938000E-01
Diabetic-vs-NonDiabetic
5.821200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.461200E-01
Normal-vs-NoPancreatitis
5.043200E-01
Pancreatitis-vs-NoPancreatitis
7.054600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.625600E-01
Normal-vs-N1
5.476200E-01
N0-vs-N1
1.295830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.515800E-01
Normal-vs-TP53-NonMutant
3.573200E-01
TP53-Mutant-vs-TP53-NonMutant
6.44989999999401E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
